三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
卡度尼利对比纳尤武利单抗/伊匹木单抗的诱导单核细胞分泌细胞因子的药理活性
卡度尼利对比纳尤武利单抗/伊匹木单抗的诱导单核细胞分泌细胞因子的药理活性
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:350KB
图片尺寸:1830*789
同报告图片
/
4
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
所属报告:
康方生物-公司投资价值分析报告:百尺竿头聚焦全球首创疗法的双抗龙头-230209(70页).pdf
打包全文图表
相关数据
结合各类细胞因子以增强免疫疗效的各类新分子
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
收藏
行业数据
2025-08-14
原图定位
查看详情
痛风急性炎症产生和自发缓解过程中参与的细胞因子
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
收藏
行业数据
2025-08-08
原图定位
查看详情
IL-1家族细胞因子及其炎症通路示意图
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
收藏
行业数据
2025-06-18
原图定位
查看详情
生成细胞因子的主要细胞类型
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
收藏
行业数据
2025-05-13
原图定位
查看详情
普鲁苏拜单抗体内外活性优于伊匹木类似物
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
收藏
行业数据
2025-03-03
原图定位
查看详情
N-Momentum:伊奈利珠单抗vs.安慰剂在AQP4-IgG+NMOSD患者中的疗效结果(RCP)
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
收藏
行业数据
2024-12-30
原图定位
查看详情
N-Momentum:伊奈利珠单抗vs.安慰剂在AQP4-IgG+NMOSD患者中的安全性表现(RCP)
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
收藏
行业数据
2024-12-30
原图定位
查看详情
阿布昔替尼的应答率及应答时间优于度普利尤单抗
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
收藏
行业数据
2024-12-12
原图定位
查看详情
度普利尤单抗与乌帕替尼、阿布西替尼安全性数据对比
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
收藏
行业数据
2024-12-05
原图定位
查看详情
2022H2-2023H2卡度尼利单抗销售额(亿元)
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
收藏
行业数据
2024-10-21
原图定位
查看详情
国内重组人粒细胞刺激因子市场较大(百万元)
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
收藏
行业数据
2024-09-24
原图定位
查看详情
参与黏膜免疫应答的细胞因子类型及特点
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
收藏
行业数据
2024-09-19
原图定位
查看详情
全球戈利木单抗销售额(亿美元)
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
收藏
其它
2024-07-12
原图定位
查看详情
中国戈利木单抗销售额(亿元)
fCDlubTku70gfCDplIDllK7pop3vvIjkur/lhYPvvIkgfCB5b3nvvIgl77yJIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAxOCB8IDAuMjQgICAgICAgICAgIHwgICAgICAgICAgfAp8IDIwMTkgfCAwLjYyICAgICAgICAgICB8IDE2MSUgICAgIHwKfCAyMDIwIHwgMS4wNyAgICAgICAgICAgfCA3MiUgICAgICB8CnwgMjAyMSB8IDEuMTcgICAgICAgICAgIHwgOSUgICAgICAgfAp8IDIwMjIgfCAxLjAyICAgICAgICAgICB8IC0xMyUgICAgIHwKfCAyMDIzIHwgMC43OSAgICAgICAgICAgfCAtMjMlICAgICB8CgrotYTmlpnmnaXmupDvvJrnsbPlhoXnvZHvvIzmtZnllYbor4HliLjnoJTnqbbmiYA=
收藏
其它
2024-07-12
原图定位
查看详情
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
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
收藏
其它
2024-07-10
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
靶点亲和力与药理活性数据优异,提供竞争优势。与 PD-1 或 CTLA-4 等靶分子的结合强度是评价免疫检查点抑制剂药效的重要指标。体外临床前实验表明,卡度尼利与 PD-1和 CTLA-4 均有极佳结合力,结合亲和力相比纳尤武利单抗/伊匹木单抗联用提高了约一个数量级。体外药理实验表明,卡度尼利诱导外周血单核细胞分泌的细胞因子 IL-2 与 IFN-γ显著高于纳尤武利单抗/伊匹木单抗联用方案,展示出更强的抗肿瘤潜力。
行业数据
原图定位
当前图表所属:
康方生物-公司投资价值分析报告:百尺竿头聚焦全球首创疗法的双抗龙头-230209(70页).pdf
卡度尼利及其他免疫疗法用于二线/三线宫颈癌治疗临床数据(非头对头对比)
PD-(L)1/CTLA-4双抗全球研发进展
纳武利尤单抗联用或不联用伊匹木单抗临床数据
国内CTLA-4单抗中后期临床试验进展(II期及以上)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》